NAB takes on Wall Street giant for $230 million

The bank joins a host of companies that claim they were misled when buying CDOs.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The National Australia Bank (ASX: NAB) has filed an arbitration claim that alleges Wall Street investment bank Goldman Sachs (NYSE: GS) misled the Aussie bank into purchasing Collateralised Debt Obligations (CDOs).

Some believe that CDOs, which are essentially pooled debt that has an asset secured to it, was a major reason the GFC hit financial markets as hard as it did. They were structured, marketed and sold as high-return, low-risk investments that bet with or against the underlying asset, in NAB's case it was the US housing market.

The particular CDO that is alleged to have lost millions of insurers' and investment companies' dollars, called 'Hudson 1', was sold to investors by Goldman, but the company didn't disclose that the firm was also betting against the market. NAB claims that the investment bank's actions were essentially common-law fraud. It added that many individuals are to blame for implementing the offer of CDOs, but addressed its claim to Goldman in general.

One of the four men who have appeared numerously in similar court cases was quoted as saying "during the early summer of 2006 it was clear that the market fundamentals in subprime and the highly levered nature of CDOs [were] going to have a very unhappy ending".

NAB's claim is expected to be resolved within 18 months as others have been before. To date, three similar cases have been filed against the investment bank, two have been thrown out by judges and one was settled for a payout of $550 million.

Foolish takeaway

Goldman Sachs is in a position similar to many other investment banks that have survived the GFC. NAB obviously sees an opportunity to redeem some lost capital, however, investors should remember that the company is valued at approximately $67 billion and the outcome will not affect the company's balance sheets in the long term. With a stable 6.4% dividend, NAB is still very attractive for income-seeking investors.

In the market for high-yielding ASX shares? Get "3 Stocks for the Great Dividend Boom" in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading


Motley Fool contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »